Notice: This company has been marked as potentially delisted and may not be actively trading. Immunovia AB (publ) (IMMVF) News Today Add Compare Share Share Headlines Stock AnalysisShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Q3 2024 Immunovia AB (publ) Earnings Call TranscriptDecember 2, 2024 | gurufocus.comImmunovia presents data from model development study at meeting of the PRECEDE pancreatic cancer research consortiumNovember 7, 2024 | prnewswire.comImmunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conferenceSeptember 16, 2024 | prnewswire.comImmunovia publishes prospectus relating to the rights issueMarch 17, 2023 | prnewswire.comImmunovia strengthens US organization to continue commercialization of its novel IMMray™ PanCan-d testDecember 5, 2022 | finance.yahoo.comCenters for Medicare & Medicaid Services finalizes its payment determination and sets a rate of $897 for Immunovia's IMMray PanCan-d testNovember 30, 2022 | finance.yahoo.comChief Executive Offier, Philipp Mathieu, buys Immunovia warrantsNovember 16, 2022 | finance.yahoo.comImmunovia announces the financial calendar for financial year 2023November 12, 2022 | finance.yahoo.comImmunovia Publishes Interim Report Jan-Sep 2022November 10, 2022 | finance.yahoo.comImmunovia AB: Invitation to Immunovia's Q3 presentationNovember 5, 2022 | finanznachrichten.deInvitation to Immunovia's Q3 presentationNovember 3, 2022 | finance.yahoo.comNomination Committee appointed for the 2023 Annual General Meeting of Immunovia AB (Publ)October 20, 2022 | finance.yahoo.comImmunovia announces executive management team changes to accelerate execution of strategic prioritiesOctober 19, 2022 | finance.yahoo.comImmunovia AB: Immunovia launches a strategic partnership with Proteomedix to leverage R&D efforts with increased focus on commercializationOctober 18, 2022 | finanznachrichten.deImmunovia launches a strategic partnership with Proteomedix to leverage R&D efforts with increased focus on commercializationOctober 17, 2022 | finance.yahoo.comAttendo International publ AB (ATTE)September 29, 2022 | investing.comCenters for Medicare & Medicaid Services issues preliminary payment rate determination for Immunovia's IMMray PanCan-d testSeptember 26, 2022 | finance.yahoo.comImmunovia publ AB (IMMNOV)September 9, 2022 | investing.comImmunovia AB: Immunovia Publishes Interim Report Jan-June 2022August 25, 2022 | finanznachrichten.deImmunovia Publishes Interim Report Jan-June 2022August 24, 2022 | finance.yahoo.comImmunovia to present at Gilmartin Group's Emerging Growth Company ShowcaseAugust 23, 2022 | finance.yahoo.comInvitation to Immunovia's Q2 presentationAugust 22, 2022 | finance.yahoo.comImmunovia, Inc. Issued Clinical and Public Health Laboratory License from California Dept of Public Health for IMMray™ PanCan-d testAugust 11, 2022 | finance.yahoo.comImmunovia: CPT PLA Code for the IMMray™ PanCan-d test approvedJuly 5, 2022 | finance.yahoo.comThe PanDIA-1 study, for early detection of pancreatic cancer in newly onset type 2 diabetics, moves into next phaseJune 30, 2022 | finance.yahoo.comPanFAM-1 Results Partly InconclusiveJune 27, 2022 | finance.yahoo.comInvitation to Immunovia's Presentation of PanFAM-1 ResultsJune 27, 2022 | finance.yahoo.comImmunovia AB appoints Philipp Mathieu as permanent CEOJune 3, 2022 | seekingalpha.comPhilipp Mathieu appointed CEO of Immunovia ABJune 2, 2022 | finance.yahoo.comImmunovia gets permits in Maryland, Pennsylvania for pancreatic cancer testMay 24, 2022 | seekingalpha.comImmunovia, Inc. market access increases when achieving Clinical Laboratory Permits from Pennsylvania and Maryland Departments of Health making IMMray™ PanCan-d test available in 48 US statesMay 23, 2022 | finance.yahoo.comImmunovia, Inc. achieves Clinical Laboratory Licensure from Rhode Island Dept of Health making IMMray™ PanCan-d test available in 46 US statesMay 17, 2022 | finance.yahoo.comImmunovia strengthens its US team through the appointment of Natalie Carfora as Head of Market Access USMay 16, 2022 | finance.yahoo.comImmunovia GAAP EPS of -SEK 1.95, revenue of SEK 0.18MApril 29, 2022 | seekingalpha.comImmunovia AB: Immunovia Publishes Interim Report January-March 2022April 28, 2022 | finanznachrichten.deImmunovia Publishes Interim Report January-March 2022April 28, 2022 | finance.yahoo.comInvitation to Immunovia's Q1 presentationApril 21, 2022 | finance.yahoo.comCommuniqué from the Annual General Meeting in Immunovia ABApril 7, 2022 | finance.yahoo.comImmunovia appoints Jeff Borcherding, previously Chief Marketing Officer at Myriad Genetics, to lead Immunovia's US businessMarch 28, 2022 | finance.yahoo.comImmunovia AB: Immunovia publishes the annual report for 2021March 10, 2022 | finanznachrichten.deImmunovia publishes the annual report for 2021March 10, 2022 | finance.yahoo.comImmunovia, Inc. Laboratory Receives Accreditation from College of American Pathologists - a major step in the nationwide US roll-out of IMMray™ PanCan-dMarch 8, 2022 | finance.yahoo.comImmunovia AB: Immunovia further strengthens IP portfolio for its IMMray PanCan-d signatureMarch 7, 2022 | finanznachrichten.deImmunovia further strengthens IP portfolio for its IMMray™ PanCan-d signatureMarch 7, 2022 | finance.yahoo.comNotice to the Annual General Meeting of Immunovia AB (publ)March 4, 2022 | finance.yahoo.comImmunovia Publishes Full Year Report 2021February 17, 2022 | finance.yahoo.comInvitation to Immunovia's Q4 presentationFebruary 4, 2022 | finance.yahoo.comImmunovia postpones Annual General Meeting pending the Temporary Meetings ActFebruary 3, 2022 | finance.yahoo.comIMMVF Real-Time QuotesJanuary 25, 2022 | nasdaq.comImmunovia AB: Immunovia appoints Philipp Mathieu as Acting CEOJanuary 20, 2022 | finanznachrichten.de Get Immunovia AB (publ) News Delivered to You Automatically Sign up to receive the latest news and ratings for IMMVF and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. IMMVF Media Mentions By Week IMMVF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMMVF News Sentiment▼0.000.60▲Average Medical News Sentiment IMMVF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMMVF Articles This Week▼00▲IMMVF Articles Average Week Get Immunovia AB (publ) News Delivered to You Automatically Sign up to receive the latest news and ratings for IMMVF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AGNPF News AKBLF News DRTSW News ARNI News ASPHF News ASCLF News AVCTF News AWKNF News AXIM News BRRGF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:IMMVF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunovia AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunovia AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
